AKT-mediated phosphorylation of TWIST1 is essential for breast cancer cell metastasis

Previously, it was shown that human TWIST1 (basic helix-loop-helix (b-HLH) is phosphorylated by Akt kinase at S42, T121, and S123. To show in vivo effect of these phosphorylations, we created mouse TWIST1 expression vector and converted the codons of S42, T125, and S127 to unphosphorylatable alanine and phosphorylation mimicking Glutamic acid. We hypothesized that alanine mutants would inhibit the metastatic ability of 4T1 cells while glutamic acid mutants would convert nonmetastatic 67NR cells into metastatic phenotype. To confirm this hypothesis, we created metastatic 4T1 and nonmetastatic 67NR cells expressing alanine mutants and glutamic acid mutants mouse TWIST1, respectively. Then, we injected 1 x 10(6) 67NR and 1 x 10(5) 4T1 cells overexpressing mutants of TWIST1 into the breast tissue of BALB/c mice. At the end of the 4th week, we sacrificed the animals, determined the numbers of tumors at lungs and liver. Although 67NR cells overexpressing wild-type TWIST1 did not show any metastasis, cells overexpressing S42E and T125E mutants showed 15-30 macroscopic metastasis to liver and lungs. Parallel to this, 4T1 cells expressing S42A and T125A mutants of TWIST1 showed no macroscopic metastasis. Our results indicate that phosphorylation of S42 and T125 by AKT is essential for TWIST1-mediated tumor growth and metastasis.

___

  • Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401
  • Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9
  • CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686
  • Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067
  • Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479
  • Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717
  • ElGhouzzi V, 1997, NAT GENET, V15, P42 .
  • Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352
  • Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001
  • Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200
  • Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36
  • Kingston RE, 2003, CALCIUM PHOSPHATE TR, V20, P20
  • Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021
  • Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722
  • Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712
  • Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144
  • Rice DPC, 2000, DEVELOPMENT, V127, P1845
  • Singh S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/215748
  • Wang DW, 2018, ONCOL REP, V39, P31, DOI 10.3892/or.2017.6076
  • Xu Y, 2017, ONCOGENE, V36, P1157, DOI 10.1038/onc.2016.286
  • Xu Y, 2013, AM J PATHOL, V183, P1281, DOI 10.1016/j.ajpath.2013.06.021
  • Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270
  • Yousfi M, 2002, BIOCHEM BIOPH RES CO, V297, P641, DOI 10.1016/S0006-291X(02)02260-X
  • Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK